Request for Comments on USPTO Initiatives To Promote Generic Drug and Biosimilar Competition
LexBlog IP
OCTOBER 25, 2022
Patent and Trademark Office (USPTO) recently published a request for comments addressing a variety of topics related to generic drug and biosimilar competition. Identify any specific sources of prior art not currently available through the Patents End-to-End Search system that you believe examiners should be searching.
Let's personalize your content